Acetaminophen Toxicity Diagnostics, LLC

Little Rock, AR Doing business as ATD

UEI
M7PNUQVP4RE3
CAGE
4KZR9
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Subchapter S Corporation
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
401 S Cedar St g43, Little Rock, AR 72205, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Acetastat validation and commercialization - james, laura p project summary/abstract acetaminophen (apap) is the most… SB1DK079387 National Institute of Diabetes and Digestive and Kidney Diseases (NIH) $6,706,987
Dipstick assay for detection of acetaminophen protein adducts R41DK079387 National Institutes of Health $488,589
Adduct dipstick for diagnosis of acetaminophen toxicity R42DK079387 National Institute of Diabetes and Digestive and Kidney Diseases (NIH) $4,365,842

Quick answers

Is Acetaminophen Toxicity Diagnostics, LLC registered in SAM.gov?

Yes. Acetaminophen Toxicity Diagnostics, LLC's SAM.gov registration is active through July 16, 2027.

What is Acetaminophen Toxicity Diagnostics, LLC's most recent federal award?

Acetaminophen Toxicity Diagnostics, LLC's most recent federal grant award is Acetastat validation and commercialization - james, laura p project summary/abstract acetaminophen (apap) is the most… (SB1DK079387), from National Institute of Diabetes and Digestive and Kidney Diseases (NIH), on April 1, 2008.

On GovTribe

See Acetaminophen Toxicity Diagnostics, LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login